SPDR® S&P Biotech ETF (XBI)
| 198.59 Data as of Jan 23 |  +2.11 / +1.07%Today’s Change | 115.31 Today|||52-Week Range 201.71 | +6.51% Year-to-Date |
Investment Objective
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Latest XBI News
| How To Profit From These 3 Overvalued Sectors Jan 23 / StreetAuthority |
Performance
| 1 month | +4.06% | 3 years | +39.67% | |
| 3 months | +23.72% | 5 years | +29.40% | |
| 1 year | +24.71% | Since inception | +17.01% |
Data through 01/23/2015
Quote Details
| Previous close | $196.48 |
| Open day’s range | -- – -- |
| Net asset value (NAV) | 196.57 (01/22/2015) |
| Daily volume | 552,758 |
| Average volume (3 months) | 532,338 |
Data as of 01/23/2015
Peer Comparisonvs. Health ETFs
| XBI | Category | |
|---|---|---|
| Performance 5-yr return | +29.40% | +22.29% |
| Expense Gross exp ratio | 0.35% | 0.44% |
| Risk 5 year sharpe ratio | 1.15 | 1.44 |
| Net assets | $1.5B | $1.5B |
| Average market cap | $2.0B | $34.2B |
| Average P/E | -- | 25.1 |
| Dividend / Share | -- | 0.21% |
Competitors
| XLV Health Care Select Sector SPDR® Fund |
| RYH Guggenheim S&P 500® Equal Weight Health... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| RPTP Raptor Pharmaceutical Corp | 1.45% |
| OPK Opko Health Inc | 1.42% |
| BCRX Biocryst Pharmaceuticals Inc | 1.41% |
| HALO Halozyme Therapeutics Inc | 1.40% |
| ENTA Enanta Pharmaceuticals Inc | 1.37% |
| NPSP NPS Pharmaceuticals Inc | 1.33% |
| ONVO Organovo Holdings Inc | 1.33% |
| ICPT Intercept Pharmaceuticals Inc | 1.32% |
| CMRX Chimerix Inc | 1.32% |
| VNDA Vanda Pharmaceuticals Inc | 1.31% |
.